Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effects of Ceftazidime Avibactam compared to Doripenem for treating hospitalized patients with complicated urinary tract infections, including acute pyelonephritis


Clinical Trial Description

A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01595438
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date October 2012
Completion date August 2014

See also
  Status Clinical Trial Phase
Completed NCT01599806 - Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) Phase 3